Rolvedon 13.2 mg/0.6 mL single-dose prefilled syringe Images
Generic Name: eflapegrastim
This medication has been identified as Rolvedon 13.2 mg/0.6 mL single-dose prefilled syringe. It is supplied by Spectrum Pharmaceuticals, Inc.
Rolvedon is used in the treatment of Neutropenia Associated with Chemotherapy and belongs to the drug class colony stimulating factors. Rolvedon 13.2 mg/0.6 mL single-dose prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Rolvedon
- Generic Name
- eflapegrastim
- Strength
- 13.2 mg/0.6 mL single-dose prefilled syringe
- Availability
- Prescription only
- Drug Class
- Colony stimulating factors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Spectrum Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 76961-0101
More about Rolvedon (eflapegrastim)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: colony stimulating factors
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
